Device Trial Radar · NCT07559708
A Study of the Sleepnet Elara APAP Device
Last checked: Nov 19, 2026Latest source record: Nov 3, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
89
Actual
Start
Apr 21, 2026
Primary completion
Oct 20, 2026
Study completion Oct 20, 2026
Sponsor
- Lead sponsor
- Sleepnet CorporationNot on our public-company list
- Sponsor type
- Industry
- First posted
- Apr 30, 2026
Design
- Study type
- Interventional
- Phase
- Not applicable (typical for device studies)
- Allocation
- Not applicable (single group)
- Model
- Single group
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated device
- Yes
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The goal of this study is to evaluate the effectiveness of the Elara APAP device.
Conditions
- Sleep Apnea - Obstructive
Interventions
Sleepnet Elara TreatmentDevice
Subject to have a 1 night in-lab PSG
Primary outcomes
What the sponsor says the trial is designed to measure.
- AHI 4%Time frame: Day 1
Locations
2 sites in 1 country. Site status is shown where the registry gives one.
University Sleep Disorders Center
Auburn, Alabama
Clayton Sleep Institute
St Louis, Missouri
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.